Comments
US FDA approves Pfizer's Inlyta for kidney cancer
28.01.2012. | WASHINGTON (Reuters) - Pfizer's Inlyta drug for patients with advanced kidney cancer won approval from U.S. regulators, boosting the company's efforts to offset plunging Lipitor sales....
